Difference between revisions of "Template:Adrenergic receptor modulators"

From blackwiki
Jump to navigation Jump to search
blackwiki>Medgirl131
m (274 revisions imported)
 
(7 intermediate revisions by 6 users not shown)
Line 37: Line 37:
 
* [[Naphazoline]]
 
* [[Naphazoline]]
 
* [[Norepinephrine]]
 
* [[Norepinephrine]]
* [[Octopamine (drug)]]
+
* [[Octopamine]]
 
* [[Oxymetazoline]]
 
* [[Oxymetazoline]]
 
* [[Phenylephrine]]
 
* [[Phenylephrine]]
Line 87: Line 87:
 
* [[Pardoprunox]]
 
* [[Pardoprunox]]
 
* [[Pelanserin]]
 
* [[Pelanserin]]
 +
* [[Perlapine]]
 
* [[Phendioxan]]
 
* [[Phendioxan]]
 
* [[Phenoxybenzamine]]
 
* [[Phenoxybenzamine]]
Line 94: Line 95:
 
* [[Prazosin]]
 
* [[Prazosin]]
 
* [[Quinazosin]]
 
* [[Quinazosin]]
 +
* [[Quinidine]]
 
* [[Ritanserin]]
 
* [[Ritanserin]]
 
* [[Silodosin]]
 
* [[Silodosin]]
Line 170: Line 172:
 
* [[Aptazapine]]
 
* [[Aptazapine]]
 
* [[Atipamezole]]
 
* [[Atipamezole]]
* [[Atypical antipsychotic]]s (e.g., [[asenapine]], [[brexpiprazole]], [[clozapine]], [[lurasidone]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[zotepine]])
+
* [[Atypical antipsychotic]]s (e.g., [[asenapine]], [[brexpiprazole]], [[clozapine]], [[lurasidone]], [[olanzapine]], [[paliperidone]], [[quetiapine]], [[risperidone]], [[zotepine]])
 
* [[Azapirone]]s (e.g., [[buspirone]], [[gepirone]], [[ipsapirone]], [[tandospirone]])
 
* [[Azapirone]]s (e.g., [[buspirone]], [[gepirone]], [[ipsapirone]], [[tandospirone]])
 
* [[BRL-44408]]
 
* [[BRL-44408]]
Line 184: Line 186:
 
* [[Mirtazapine]]
 
* [[Mirtazapine]]
 
* [[NAN-190]]
 
* [[NAN-190]]
* [[Olanzapine]]
 
 
* [[Pardoprunox]]
 
* [[Pardoprunox]]
 
* [[Phentolamine]]
 
* [[Phentolamine]]
Line 389: Line 390:
 
* [[Xipranolol]]
 
* [[Xipranolol]]
  
| below =
+
|group4 = See<br/>also
* <small>'''''See also:''' [[Template:Receptor modulators|Receptor/signaling modulators]]''
+
|list4 = *[[List of adrenergic drugs]]
* ''[[Template:Dopaminergics|Dopaminergics]]''
 
* ''[[Template:Serotonergics|Serotonergics]]''
 
* ''[[Template:Monoamine reuptake inhibitors|Monoamine reuptake inhibitors]]''
 
* ''[[Template:Monoamine releasing agents|Monoamine releasing agents]]''
 
* ''[[Template:Monoamine metabolism modulators|Monoamine metabolism modulators]]''
 
* ''[[Template:Monoamine neurotoxins|Monoamine neurotoxins]]''</small>
 
  
}}
+
 
<noinclude>
+
}}<noinclude>
 
{{documentation | content =
 
{{documentation | content =
 
{{collapsible option}}
 
{{collapsible option}}
{{pp-semi-indef}}
 
 
[[Category:Drug templates by receptor, channel, or pump]]
 
[[Category:Drug templates by receptor, channel, or pump]]
 
}}</noinclude>
 
}}</noinclude>

Latest revision as of 10:17, 18 October 2020

Template documentation

Initial visibility: currently defaults to autocollapse

To set this template's initial visibility, the |state= parameter may be used:

  • |state=collapsed: {{Adrenergic receptor modulators|state=collapsed}} to show the template collapsed, i.e., hidden apart from its title bar
  • |state=expanded: {{Adrenergic receptor modulators|state=expanded}} to show the template expanded, i.e., fully visible
  • |state=autocollapse: {{Adrenergic receptor modulators|state=autocollapse}}
    • shows the template collapsed to the title bar if there is a {{navbar}}, a {{sidebar}}, or some other table on the page with the collapsible attribute
    • shows the template in its expanded state if there are no other collapsible items on the page

If the |state= parameter in the template on this page is not set, the template's initial visibility is taken from the |default= parameter in the Collapsible option template. For the template on this page, that currently evaluates to autocollapse.